Altimmune (ALT) Shares Issued (2010 - 2026)

Altimmune (ALT) has 17 years of Shares Issued data on file, last reported at $177000.0 in Q1 2026.

• Shares Issued for Q1 2026 came in at $177000.0, up 4.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $48000.0 (down 99.52% YoY), and the FY2025 annual result was $41000.0, down 99.59% from the prior year.
• Shares Issued improved to $177000.0 in Q1 2026 per ALT's latest filing, from -$112.0 million in the prior quarter.
• Over five years, Shares Issued peaked at $112.1 million in Q3 2025 and troughed at -$112.0 million in Q4 2025.
• A 5-year average of $6.5 million and a median of $131000.0 in 2024 frame the typical range for Shares Issued.
• On a YoY basis, Shares Issued climbed as much as 85457.25% in 2025 and fell as far as 2125.0% in 2025.
• A 5-year view of Shares Issued shows it stood at -$687000.0 in 2022, then soared by 12696.8% to $86.5 million in 2023, then slumped by 88.8% to $9.7 million in 2024, then slumped by 1255.84% to -$112.0 million in 2025, then soared by 100.16% to $177000.0 in 2026.
• Business Quant data shows ALT's Shares Issued at $177000.0 in Q1 2026, -$112.0 million in Q4 2025, and $112.1 million in Q3 2025.